{"id":"https://openalex.org/W139903447","doi":null,"title":"Subcutaneous Fat Accumulation and Thiazolidinedione Derivatives : Sex Differences and Their Relation to Glycemic Control","display_name":"Subcutaneous Fat Accumulation and Thiazolidinedione Derivatives : Sex Differences and Their Relation to Glycemic Control","publication_year":2003,"publication_date":"2003-06-10","ids":{"openalex":"https://openalex.org/W139903447","mag":"139903447"},"language":"en","primary_location":{"id":"pmh:oai:ir.jikei.ac.jp:10328/1777","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10328/1777","pdf_url":"http://hdl.handle.net/10328/1777","source":{"id":"https://openalex.org/S4306400672","display_name":"The Academic Repository of The Jikei University School of Medicine (Jikei University School of Medicine)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I115498069","host_organization_name":"Jikei University School of Medicine","host_organization_lineage":["https://openalex.org/I115498069"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The Jikei University School of Medicine","raw_type":"article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/10328/1777","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161270311","display_name":"\u79c0\u660e \u5c0f\u5bae","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u79c0\u660e \u5c0f\u5bae","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026334490","display_name":"Hideaki Komiya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u4fee\u884c \u9ed2\u5ddd","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5020963840","display_name":"Naoyuki Kurokawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u5c1a\u5b50 \u7530\u5dbc","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"50","issue":"2","first_page":"85","last_page":"91"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8413000106811523,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8413000106811523,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.1031000018119812,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.017000000923871994,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/troglitazone","display_name":"troglitazone","score":0.9100000262260437},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9919999837875366},{"id":"https://openalex.org/keywords/subcutaneous-adipose-tissue","display_name":"subcutaneous adipose tissue","score":0.8489999771118164},{"id":"https://openalex.org/keywords/body-fat-distribution","display_name":"body fat distribution","score":0.7599999904632568},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.8849999904632568},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9039999842643738},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9300000071525574},{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":0.9409999847412109},{"id":"https://openalex.org/keywords/visceral-fat","display_name":"visceral fat","score":0.8479999899864197},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9549999833106995},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.9559999704360962}],"concepts":[{"id":"https://openalex.org/C2778150266","wikidata":"https://www.wikidata.org/wiki/Q7844989","display_name":"Troglitazone","level":4,"score":0.9837008118629456},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7930098176002502},{"id":"https://openalex.org/C2779768347","wikidata":"https://www.wikidata.org/wiki/Q420626","display_name":"Glibenclamide","level":3,"score":0.7474327087402344},{"id":"https://openalex.org/C2776923340","wikidata":"https://www.wikidata.org/wiki/Q1393556","display_name":"Thiazolidinedione","level":4,"score":0.6893423795700073},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.6637372970581055},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.638114333152771},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5915918946266174},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5484018921852112},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.4944758415222168},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4486232399940491},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.08463731408119202},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.05765542387962341}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:ir.jikei.ac.jp:10328/1777","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10328/1777","pdf_url":"http://hdl.handle.net/10328/1777","source":{"id":"https://openalex.org/S4306400672","display_name":"The Academic Repository of The Jikei University School of Medicine (Jikei University School of Medicine)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I115498069","host_organization_name":"Jikei University School of Medicine","host_organization_lineage":["https://openalex.org/I115498069"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The Jikei University School of Medicine","raw_type":"article"},{"id":"pmh:oai:irdb.nii.ac.jp:00939:0002897559","doi":null,"is_oa":true,"landing_page_url":"https://ir.jikei.ac.jp/records/205","pdf_url":"https://ir.jikei.ac.jp/record/205/files/50-2-85.pdf","source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Jikeikai medical journal","raw_type":"journal article"},{"id":"mag:575721177","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/naid/120000791166","pdf_url":null,"source":{"id":"https://openalex.org/S2764561478","display_name":"Jikeikai medical journal","issn_l":"0021-6968","issn":["0021-6968"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310313436","host_organization_name":"Jikei University School of Medicine","host_organization_lineage":["https://openalex.org/P4310313436"],"host_organization_lineage_names":["Jikei University School of Medicine"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Jikeikai medical journal","raw_type":null}],"best_oa_location":{"id":"pmh:oai:ir.jikei.ac.jp:10328/1777","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10328/1777","pdf_url":"http://hdl.handle.net/10328/1777","source":{"id":"https://openalex.org/S4306400672","display_name":"The Academic Repository of The Jikei University School of Medicine (Jikei University School of Medicine)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I115498069","host_organization_name":"Jikei University School of Medicine","host_organization_lineage":["https://openalex.org/I115498069"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The Jikei University School of Medicine","raw_type":"article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W139903447.pdf","grobid_xml":"https://content.openalex.org/works/W139903447.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W127554605","https://openalex.org/W2000821877","https://openalex.org/W2019396524","https://openalex.org/W2020949125","https://openalex.org/W2025001072","https://openalex.org/W2027360957","https://openalex.org/W2047591801","https://openalex.org/W2057180728","https://openalex.org/W2060899732","https://openalex.org/W2062560800","https://openalex.org/W2065271302","https://openalex.org/W2085608095","https://openalex.org/W2125090169","https://openalex.org/W2129316761"],"related_works":["https://openalex.org/W575721177","https://openalex.org/W2033752591","https://openalex.org/W1999236387","https://openalex.org/W2107207934","https://openalex.org/W1987692887","https://openalex.org/W2019396524","https://openalex.org/W2131633712","https://openalex.org/W2085608095","https://openalex.org/W2036873878","https://openalex.org/W2137485270"],"abstract_inverted_index":{"We":[0],"investigated":[1],"changes":[2,93,161],"in":[3,76,85,96,102,108,113,122,134,172,182,191,201],"body":[4,71],"fat":[5,101,110,148,193],"distribution":[6],"during":[7],"long-term":[8],"treatment":[9,104,195],"with":[10,26,139],"troglitazone":[11,19,37,61,82,119],"and":[12,34,42,47,58,70,79,84,90,116,121,127,167,196],"its":[13],"effect":[14],"on":[15],"glycemic":[16,176],"control.We":[17],"administered":[18],"at":[20],"400":[21],"mg/day":[22],"to":[23,188,197],"40":[24],"outpatients":[25],"type":[27],"2":[28],"diabetes.Twenty-one":[29],"drug-naive":[30],"patients":[31,44,138,163],"(8":[32],"men":[33,46,78,115],"13":[35],"women)received":[36],"monotherapy":[38],"for":[39,62],"16":[40,63],"months,":[41],"19":[43],"(10":[45],"9":[48],"women)":[49],"who":[50],"had":[51,159],"been":[52],"receiving":[53,81,87,118,124,151,164],"glibenclamide":[54,89,126,166],"continued":[55],"this":[56],"drug":[57],"also":[59],"received":[60],"months.Levels":[64],"of":[65,99,137,142,157,175],"glycosylated":[66],"hemoglobin":[67,144],"significantly":[68,74,154],"decreased":[69],"mass":[72],"index":[73],"increased":[75,146],"the":[77,97,114,135,173,189,202],"women":[80,86,117,123,158],"alone":[83,120],"both":[88,125,165],"troglitazone.No":[91],"significant":[92,106],"were":[94],"observed":[95,112,133],"area":[98],"visceral":[100],"any":[103],"group.A":[105],"increase":[107,190],"subcutaneous":[109,147,192,203],"was":[111,132],"troglitazone.Although":[128],"no":[129],"sex":[130,170],"difference":[131,171,200],"percentages":[136],"reduced":[140],"levels":[141],"gycosylated":[143],"or":[145],"among":[149,162],"those":[150],"troglitazone,":[152],"a":[153,198],"higher":[155],"percentage":[156],"these":[160],"troglitazone.The":[168],"apparent":[169],"degree":[174],"control":[177],"produced":[178],"by":[179],"thiazolidinedione":[180],"therapy":[181],"our":[183],"subjects":[184],"can":[185],"be":[186],"attributed":[187],"after":[194],"pretreatment":[199],"fat.(Jikeikai":[204],"Med":[205],"J":[206],"2003;":[207],"50:":[208],"85-91)":[209]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2025-10-10T00:00:00"}